Medplus Health

37
Sell
  • Market Cap: Small Cap
  • Industry: Retailing
  • ISIN: INE804L01022
  • NSEID: MEDPLUS
  • BSEID: 543427
INR
704.95
-9.6 (-1.34%)
BSENSE

Jul 31, 03:30 PM

BSE+NSE Vol: 8.39 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Operating Income
6,892.00
6,136.00
5,624.00
4,557.00
3,779.00
3,069.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
6,892.00
6,136.00
5,624.00
4,557.00
3,779.00
3,069.00
Expenditure (Ex Depriciation)
Stock Adjustments
-34.00
6.00
-190.00
-221.00
-159.00
-105.00
Raw Materials Consumed
5,119.00
4,634.00
4,582.00
3,778.00
3,141.00
2,530.00
Power & Fuel Cost
55.00
52.00
45.00
31.00
17.00
13.00
Employee Cost
884.00
726.00
625.00
545.00
393.00
338.00
Operating Expenses
156.00
124.00
82.00
65.00
44.00
28.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
35.00
43.00
51.00
35.00
30.00
19.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
6.00
7.00
6.00
5.00
4.00
1.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
6,285.00
5,648.00
5,270.00
4,291.00
3,506.00
2,852.00
Operating Profit (PBDIT) excl Other Income
607.00
487.00
354.00
265.00
272.00
216.00
Other Income
71.00
48.00
40.00
46.00
31.00
21.00
Operating Profit (PBDIT)
678.00
535.00
394.00
311.00
303.00
238.00
Interest
120.00
102.00
96.00
83.00
66.00
54.00
Profit before Depriciation and Tax
558.00
433.00
297.00
228.00
237.00
183.00
Depreciation
282.00
249.00
224.00
181.00
119.00
88.00
Profit Before Taxation & Exceptional Items
275.00
183.00
73.00
47.00
117.00
95.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
275.00
183.00
73.00
47.00
117.00
95.00
Provision for Tax
55.00
33.00
7.00
-2.00
23.00
31.00
Profit After Tax
219.00
150.00
65.00
50.00
94.00
63.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
429.00
279.00
213.00
163.00
66.00
1.00
Profit Available for appropriations
649.00
429.00
279.00
213.00
161.00
65.00
Appropriations
649.00
429.00
279.00
213.00
161.00
65.00
Equity Dividend (%)
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Earnings Per Share
18.33
12.57
5.48
4.17
8.55
6.13
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 12.33% vs 9.09% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 24.69% vs 37.57% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 17.46% vs 6.38% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 46.18% vs 129.09% in Mar 2025

Compare Profit and Loss Results of Medplus Health
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
6,892.00
7,829.00
-937.00
-11.97%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
6,892.00
7,829.00
-937.00
-11.97%
Expenditure (Ex Depriciation)
Stock Adjustments
-34.00
140.00
-174.00
-124.29%
Raw Materials Consumed
5,119.00
3,131.00
1,988.00
63.49%
Power & Fuel Cost
55.00
88.00
-33.00
-37.50%
Employee Cost
884.00
918.00
-34.00
-3.70%
Operating Expenses
156.00
681.00
-525.00
-77.09%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
35.00
472.00
-437.00
-92.58%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
6.00
61.00
-55.00
-90.16%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
6,285.00
6,606.00
-321.00
-4.86%
Operating Profit (PBDIT) excl Other Income
607.00
1,223.00
-616.00
-50.37%
Other Income
71.00
77.00
-6.00
-7.79%
Operating Profit (PBDIT)
678.00
1,300.00
-622.00
-47.85%
Interest
120.00
413.00
-293.00
-70.94%
Profit before Depriciation and Tax
558.00
887.00
-329.00
-37.09%
Depreciation
282.00
705.00
-423.00
-60.00%
Profit Before Taxation & Exceptional Items
275.00
181.00
94.00
51.93%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
275.00
83.00
192.00
231.33%
Provision for Tax
55.00
23.00
32.00
139.13%
Profit After Tax
219.00
59.00
160.00
271.19%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
429.00
0.00
429.00
0%
Profit Available for appropriations
649.00
59.00
590.00
1,000.00%
Appropriations
649.00
59.00
590.00
1,000.00%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
18.33
0.49
17.84
3,640.82%
Profit And Loss - Net Sales
Net Sales 6,892.47 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 12.33% vs 9.09% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 607.37 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 24.69% vs 37.57% in Mar 2025

Profit And Loss - Interest
Interest 120.49 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 17.46% vs 6.38% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 219.61 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 46.18% vs 129.09% in Mar 2025